@BiomedicalRX Avatar @BiomedicalRX BioMedicalRx ๐Ÿงฌ ๐Ÿ‡บ๐Ÿ‡ธ โœ๏ธ

BioMedicalRx ๐Ÿงฌ ๐Ÿ‡บ๐Ÿ‡ธ โœ๏ธ posts on X about $ipsc, $crbu, $arwr, $crsp the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [---------] #

CreatorRank Line Chart

Social Influence

Social category influence stocks 62.3% finance 22.13% cryptocurrencies 9.84% technology brands 1.64% social networks 0.82% celebrities 0.82% vc firms 0.82%

Social topic influence $ipsc #1, $crbu #16, $arwr #29, $crsp #20, $xbi 13.11%, $sana #7, $fate #2, $prme #28, $beam #91, $xers #8

Top accounts mentioned or mentioned by @yaireinhorn @jessiechimni @biotech2k1 @arrowheadpharma @steve2bacon @ny197247 @cariboubio @pfizer @geneinvesting @intelliatx @razorsharpdna @tricoloredeel @biotechxguru @dadbod4evah @kholov23 @davidwainer @carolynyjohnson @crisprsam @albertbourla @cariboubios

Top assets mentioned Century Therapeutics, Inc. (IPSC) Caribou Biosciences, Inc. (CRBU) Arrowhead Research Corporation (ARWR) CRISPR Therapeutics AG (CRSP) Sana Biotechnology, Inc. (SANA) Prime Medicine, Inc. (PRME) BEAM (BEAM) Intellia Therapeutics, Inc (NTLA) Metagenomi Technologies, LLC (MGX) BridgeBio Pharma, Inc. Common Stock (BBIO) Kyverna Therapeutics, Inc. (KYTX) ArbitrageCT (ARCT) SPDR S&P [---] ETF Trust (SPY) Sarepta Therapeutics, Inc. (SRPT) Eli Lilly and Company (LLY) Huma Finance (HUMA) Verve Therapeutics Inc. (VERV) Muhdo Hub (DNA) Bitcoin (BTC) Moderna Inc (MRNA)

Top Social Posts

Top posts by engagements in the last [--] hours

"@tricoloredeel @BiotechXGuru @Dadbod4evah I like $CRBU as they approach a phase [--] trial for NHL. I also like how Rachel runs things Like $MGX as a trading vehicle"
X Link 2025-12-23T20:13Z [----] followers, [---] engagements

"My concentrated / conviction biotech companies for [----] $PRME - moderate risk $FATE - mild to moderate risk $ARWR - less risk $IPSC - very high risk $XERS - less risk As normal I plan to trade aggressively around core positions. I do not intend to get myself into another pickle with relentless buying (IPSC) dips anymore. One of these times Ill be forced to eat a large loss (luck runs out). Also not a complete list. Not advice high risk overall. https://twitter.com/i/web/status/2009768815878623458 https://twitter.com/i/web/status/2009768815878623458"
X Link 2026-01-09T23:26Z [----] followers, [----] engagements

"$IPSC over [--] .34 was recent low ๐Ÿ˜ฒ"
X Link 2026-01-12T20:53Z [----] followers, [----] engagements

"$PRME room to run to 5-6 if it can overcome resistance here"
X Link 2026-01-13T05:29Z [----] followers, [----] engagements

"$IPSC moving @steve2bacon @kholov23"
X Link 2026-01-13T18:01Z [----] followers, [---] engagements

"Deep Track with 13.4M shares $IPSC BIG https://investors.centurytx.com/static-files/78d1c71b-f67e-4517-9dd4-868dbbcbb5a1 https://investors.centurytx.com/static-files/78d1c71b-f67e-4517-9dd4-868dbbcbb5a1"
X Link 2026-01-16T06:41Z [----] followers, [---] engagements

"$IPSC legit. +Not included due to no recent filings - Versant [----] M Bayer - [----] M Fuji [----] M"
X Link 2026-01-16T06:50Z [----] followers, [----] engagements

"No plans for a reverse share split ๐Ÿ”ฅ $IPSC"
X Link 2026-01-23T22:13Z [----] followers, [----] engagements

"Kudos to the entire c-suite at $IPSC Brent has regained my trust and love the correct direction Century is taking. Now share price will depend on data and execution. What always fascinates me is how sentiment changes with share price. Folks has 6+ months to buy shares around .5 https://twitter.com/i/web/status/2015131546068595148 https://twitter.com/i/web/status/2015131546068595148"
X Link 2026-01-24T18:36Z [----] followers, [----] engagements

"$IPSC Investors [--] months ago vs now -"
X Link 2026-01-25T05:11Z [----] followers, [----] engagements

"$IPSC unrelenting strength ๐Ÿ”ฅ"
X Link 2026-01-27T16:41Z [----] followers, [----] engagements

"$IPSC gap fill we will have to see which way it moves now. Some consolidation would likely be good for the stock"
X Link 2026-01-29T16:35Z [----] followers, [---] engagements

"RT @yaireinhorn: 1/In this great piece - WSJs excellent columnist @david_wainer is shedding light on a very interesting and somewhat predi"
X Link 2026-01-30T16:46Z [----] followers, [--] engagements

"RT @yaireinhorn: Here is Eli Lillys $LLY CEO Dave Ricks - one of the top-notch CEOs in the Pharma and BioTech ecosystem explaining how th"
X Link 2026-01-30T23:01Z [----] followers, [--] engagements

"@ny1972_47 They are playing with fire imo"
X Link 2026-01-31T17:50Z [----] followers, [---] engagements

"@ny1972_47 Thats the crazy thing with $IPSC s move it wasnt a short squeeze even remotely $FATE has that capability to squeeze"
X Link 2026-01-31T18:45Z [----] followers, [---] engagements

"Seeing stock futures and cryptocurrencies down nicely the 10-year creeping up and SILVER very green ๐Ÿ‘‡ Lets hope biotech bucks can be contrarian tomorrow ๐Ÿ™ $BTC $XBI $SPY $ARKG"
X Link 2026-02-02T02:53Z [----] followers, [---] engagements

"@steve2bacon silver was up 7% and now flat"
X Link 2026-02-02T03:46Z [----] followers, [---] engagements

"Wonderful content on genetic engineering and its exciting applications for debilitating conditions and conditions where no cures exist. Thank you @yaireinhorn for sharing this article and the nice write up. $BEAM $CRSP $NTLA $XBI 1/In one of the best articles that Ive read recently - Washington Posts excellent science reporter @Carolynyjohnson sheds light on a less known aspect of the Gene Therapy and CRISPR Gene Editing field. Although many Gene Therapies and CRISPR Gene Editing therapies are https://t.co/4e2uLzrpx6 1/In one of the best articles that Ive read recently - Washington Posts"
X Link 2026-02-03T03:15Z [----] followers, [----] engagements

"RT @yaireinhorn: One of the most accurate descriptions of the unbearable situation - in which many Gene Therapies and CRISPR Gene Editing t"
X Link 2026-02-04T15:47Z [----] followers, [--] engagements

"@JessieChimni @CrisprSam ๐Ÿ‘ $CRSP. Sounds very promising"
X Link 2026-02-08T21:00Z [----] followers, [---] engagements

"Very well done $CRBU and strong data imo @CaribouBio ๐Ÿ‘ Thanks for the great write up @yaireinhorn Likey will re-enter here in coming months. Pure cell therapy plays I like for [----] include CRBU $IPSC $FATE 1/๐ŸšจWOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011 CaMMouflage phase [--] clinical trial in cancer patients with relapsed or refractory multiple myeloma (r/r MM). The CB-011 CaMMouflage phase [--] translational and clinical data - which was presented at https://t.co/emfrwEHgux 1/๐ŸšจWOW $CRBU has presented updated clinical data from @CaribouBio ongoing CB-011"
X Link 2026-02-09T16:30Z [----] followers, [----] engagements

"@yaireinhorn @pfizer @CaribouBio @AlbertBourla That has always been a thought Ive had Would make sense bilaterally"
X Link 2026-02-10T20:01Z [----] followers, [---] engagements

"RT @yaireinhorn: In my opinion its worth emphasising the deep involvement of @pfizer in @CaribouBios CB-011 ๐Ÿงต๐Ÿ‘‡- which is currently one of"
X Link 2026-02-10T20:01Z [----] followers, [--] engagements

"Been a while. Added $IPSC @ 1.81"
X Link 2026-02-11T20:35Z [----] followers, [---] engagements

"Not sure I could consistently drink 20g of creatine I would love that cognitive bump though A SINGLE 20g dose of creatine increases cognitive processing speed by 24.5% within [---] hours. A placebo-controlled trial found that creatine rapidly enhanced brain bioenergetics and improved cognitive performance during sleep deprivation with effects lasting up to nine hours. https://t.co/4mjYJcTBI6 A SINGLE 20g dose of creatine increases cognitive processing speed by 24.5% within [---] hours. A placebo-controlled trial found that creatine rapidly enhanced brain bioenergetics and improved cognitive"
X Link 2026-02-12T04:29Z [----] followers, [---] engagements

"RT @yaireinhorn: Congrats to @john_evans3 - @beamtx CEO on being a part of the TIME100s Health list which includes the [---] most influent"
X Link 2026-02-14T18:37Z [----] followers, [--] engagements

"$IPSC by my calculation there are now 263.4M shares. Thus actual current MC = [-----] M. That is pretty insane when the MC got as low as [---] M. TCG actually has [--] M shares We will have to see how much some of these massive shareholders sell (the filing simply allows them to sell) https://investors.centurytx.com/static-files/6c19591c-13a8-4adb-a6da-27ac572ab189 https://investors.centurytx.com/static-files/6c19591c-13a8-4adb-a6da-27ac572ab189"
X Link 2026-02-13T03:28Z [----] followers, [----] engagements

"$IPSC likely incorrect above and actually [---] M shares thus MC = [---] M"
X Link 2026-02-13T22:45Z [----] followers, [---] engagements

"Updated biotech holdings (March 2025) *in order of size No significant changes and size of position based off of appreciation / depreciation of valuations. $XERS - took some profits finally $ARWR $CRSP $BBIO $IPSC $FATE $HUMA $CRBU $AUTL - new used funds from XERS $BEAM $ARCT $KYTX $PRME $MGX - new used funds from XERS hedges are cash $SGOV $TLT $BIL patience use of money I do not need anytime soon. Last [--] hedges are essential in biotech imho Trying to avoid putting new money into biotech due to sentiment and consequent performance. My strategy is basically trying to have a few big successes"
X Link 2025-03-21T22:04Z [----] followers, 18.3K engagements

"Updated holdings - June [----] ** denotes a concentrated position Commercial $BBIO ** $SRPT $ACRT $CRSP $XERS ** Pre-revenue $ARWR ** $FATE** $BEAM $VERV $NTLA $IPSC ** $KYTX $MGX $ARCT $PRME"
X Link 2025-06-08T17:40Z [----] followers, 10.2K engagements

"Demand continues ๐Ÿคฉ $PRME"
X Link 2025-07-14T19:40Z [----] followers, [----] engagements

"@yaireinhorn @Biotech2k1 Exactly"
X Link 2026-02-15T20:59Z [----] followers, [---] engagements

"$IPSC more filings done. Ownership now very different ๐Ÿ”ฅ"
X Link 2026-01-16T21:38Z [----] followers, [----] engagements

"For comparison - $SANa and $FATE FATE is way too cheap. @JessieChimni"
X Link 2026-02-13T03:30Z [----] followers, [----] engagements

"$IPSC $FATE $SANA would love to see one of these companies take a stab at Parkinsons disease. Massive TAM and huge unmet need. https://pmc.ncbi.nlm.nih.gov/articles/PMC11881713/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11881713/"
X Link 2026-02-14T04:47Z [----] followers, [---] engagements

"Expect this to change for [----] @yaireinhorn My contacts here in San Diego expect quite a bit of $$ and deals this year. $XBI $ARKG This excellent ๐Ÿ“Š๐Ÿ‘‡ - from Stifels @TimOpler excellent & comprehensive BioTech & Pharma market outlook shows clearly that the BioTech M&A Market Activity in [----] has significantly slowed down and the pace - based on January numbers is well below last years result and without https://t.co/SD5lR6RLcu This excellent ๐Ÿ“Š๐Ÿ‘‡ - from Stifels @TimOpler excellent & comprehensive BioTech & Pharma market outlook shows clearly that the BioTech M&A Market Activity in [----] has"
X Link 2026-02-15T20:36Z [----] followers, [----] engagements

"$IPSC Clear Street reiterates Buy rating on Century Therapeutics stock at $6.60 Allo-evasion - best in class potential"
X Link 2026-02-16T03:00Z [----] followers, [----] engagements

"๐Ÿ’ฏ agree $IPSC $CRSP $SANA * long Century Therapeutics T1D is the next obesity like space. chasers gonna chase in 3-5yrs. real ones lining it up now T1D is the next obesity like space. chasers gonna chase in 3-5yrs. real ones lining it up now"
X Link 2026-02-16T03:16Z [----] followers, [----] engagements

"$MRNA will buy $SGMO within one year. Mark this post. $xbi"
X Link 2021-08-06T02:49Z [----] followers, [--] engagements

"$xbi good sign. Glad Im not the only value buyer here"
X Link 2021-12-05T19:10Z [----] followers, [--] engagements

"This is what its all about"
X Link 2022-01-01T17:53Z [----] followers, [--] engagements

"$SANA should remain volatile. Very early stage play yet has gigantic potential (Fusogen). Should be an exciting upcoming few years; [--] INDs this year goals and 2-3 INDs per year going forward"
X Link 2022-02-04T04:48Z [----] followers, [--] engagements

"$xbi contrarian opinion. My speculation is we see 300-400 in 3-5 years. Crispr protein degraders and gene editing etc etc hype will max as these treatments completely change medicine. Will be a huge bubble that has some justification"
X Link 2022-02-07T00:34Z [----] followers, [--] engagements

"$SANA I had a small position in SANA when their ASH data was presented (12/12/21) and think I under appreciated how exciting the data was. This is now one of largest biotech plays I have and will continue to accumulate unless thesis is rejected. ๐Ÿ‘ https://ir.sana.com/node/7196/pdf https://ir.sana.com/node/7196/pdf"
X Link 2022-03-13T03:03Z [----] followers, [--] engagements

"So impressed w my wife texted her the frustrations of biotech and the general market right now. She texted back one word - OPPORTUNITY. $XBI"
X Link 2022-03-14T22:03Z [----] followers, [--] engagements

"Congrats at @Biotech2k1 on [-----] followers Ill speak for many and thank you for all your valuable input and education. Your commend of science is top notch Appreciate your contribution to biotech Number [--] biotech follow imho"
X Link 2022-04-01T22:45Z [----] followers, [--] engagements

"Was just showing/ presenting my big biotech positions to my wife in this order - $AUTL $SANA $IPSC $CRBU and $PACB. My comment was $SANA has the most potential to make us A lot of money. How much My response was A LOT w risk. ๐Ÿ”ฅ. Yes I like the cell therapy space ๐Ÿ˜‰"
X Link 2022-04-16T02:18Z [----] followers, [--] engagements

"$SANA Ill choose to be early here and accept the risk of failure. SANA fits in my portfolio as a play that may not work out but has the potential to be a game changer. Nice summary here and contrary to some folks opinion Im a huge fan of Steve Harr. https://www.biospace.com/article/sana-on-track-to-remove-barriers-for-cell-and-gene-therapy-/ https://www.biospace.com/article/sana-on-track-to-remove-barriers-for-cell-and-gene-therapy-/"
X Link 2022-04-24T02:57Z [----] followers, [--] engagements

"$xbi note- the xbi is not going to zero. Who knows how low it can go but selling here or shorting biotech seems pretty counterintuitive. Not advice rather my opinion. What timeframe do you have and do you need the money invested anytime soon; that is a big variable"
X Link 2022-04-27T01:33Z [----] followers, [--] engagements

"$SANA I think SC451 will be one of the most exciting stories to watch unfold in the coming years. Valuation will sky rocket if data is positive. Huge market"
X Link 2022-08-20T22:23Z [----] followers, [--] engagements

"25 shares per week for $BEAM for next [--] months for long term hold account. Ill admit I struggle w BEAMS valuation but cant deny its potential and love the space"
X Link 2022-08-21T22:32Z [----] followers, [--] engagements

"If you invest in biotech and dont follow @Biotech2k1 you are doing yourself a disservice. He may not always tell you what you want to hear but his calls and translating science to stock prices is pretty remarkable"
X Link 2022-09-08T20:29Z [----] followers, [--] engagements

"$DNA do I own this company for its Q3 earnings in [----] ๐Ÿ˜‚. Lets see earnings in 2030"
X Link 2022-11-14T22:02Z [----] followers, [--] engagements

"$SANA $CRSP $IPSC not sure about others but I have ZERO sympathy for shorts in biotech at this juncture"
X Link 2023-04-13T14:10Z [----] followers, [----] engagements

"Worth the read and hard not to be excited for $ARWR. Pulmonary skeletal muscle and CNS programs will be very interesting to observe. #TRIM https://ir.arrowheadpharma.com/static-files/5f99ef7b-1730-4099-9aae-2521c27c67f1 https://ir.arrowheadpharma.com/static-files/5f99ef7b-1730-4099-9aae-2521c27c67f1"
X Link 2023-05-13T05:52Z [----] followers, [----] engagements

"Biotech is obviously difficult and even more so the past few years. Yet the beauty / challenge is how quickly things can change. Look at sentiment and price movement of $CRBU over the last week. the challenge is knowing when patience is required Vs time to dump a loser"
X Link 2023-07-07T21:50Z [----] followers, [----] engagements

"@SteveWagsInvest Why my net worth is very tied to the good old $SPY. Buy weekly without fail. Wisdom from buffet"
X Link 2023-09-16T22:05Z [----] followers, [---] engagements

"$FRLN good old Syncona. What a disaster ๐Ÿ‘ https://www.marketwatch.com/amp/story/syncona-seeks-to-buy-remaining-shares-of-freeline-therapeutics-1401fc74 https://www.marketwatch.com/amp/story/syncona-seeks-to-buy-remaining-shares-of-freeline-therapeutics-1401fc74"
X Link 2023-10-19T02:17Z [----] followers, [---] engagements

"$CRBU sky was falling around [----] and now everyone is bullish. That was fear I was happy to buy"
X Link 2023-11-15T15:40Z [----] followers, [----] engagements

"Hold the F line $IPSC"
X Link 2023-11-16T17:47Z [----] followers, [----] engagements

"W $CRSP near [--] again time to thank @Biotech2k1 for EDUCATING me why CRISPR may be much more successful than ZFN. Why I appreciate him not for any of his investment goals but for his willingness to patient teach - make tough stuff digestible. ๐Ÿ™"
X Link 2023-11-17T23:53Z [----] followers, [----] engagements

"$CRSP swing shares all now sold and holding core. Need to take out [--] here ๐Ÿ”ฅ - was tough resistance last May. Great company imho"
X Link 2023-11-20T14:44Z [----] followers, [----] engagements

"Best of luck to all holding through tomorrows decision. $CRSP Also important to appreciate how big of a day it is for patients in need. Science is amazing and progressing at a rapid speed. Medicine likely looks very doffernt in coming decades"
X Link 2023-12-07T23:16Z [----] followers, [----] engagements

"$CRSP congratulations @CRISPRTX $CRSP ๐Ÿ”ธ FDA Approves Vertex Pharmaceuticals and Crispr Therapeutics' Casgevy for Sickle-Cell Disease -- WSJ ๐Ÿ”ธ Casgevy Is the First Approved Treatment Using Crispr Gene-Editing Technology -- WSJ ๐Ÿ”ธ Casgevy Helped Stop Nearly All Pain Crises from Sickle-Cell Disease in a Study $CRSP ๐Ÿ”ธ FDA Approves Vertex Pharmaceuticals and Crispr Therapeutics' Casgevy for Sickle-Cell Disease -- WSJ ๐Ÿ”ธ Casgevy Is the First Approved Treatment Using Crispr Gene-Editing Technology -- WSJ ๐Ÿ”ธ Casgevy Helped Stop Nearly All Pain Crises from Sickle-Cell Disease in a Study"
X Link 2023-12-08T16:31Z [----] followers, [----] engagements

"I dont think enough people appreciate the skill @Biotech2k1 has in analyzing foundational science and early pre-clinical data and determining what will and what will not work clinically long run. Truly impressive $XBI $ARKG ๐Ÿงฌ๐Ÿ”ฅ I recommend follow if you dont already"
X Link 2023-12-10T00:18Z [----] followers, [----] engagements

"I was critical of $IPSC over the summer / fall for quietness. I was wrong - [--]. Landed an excellent CEO [--]. Progressed CNY-101 [--]. In the background was completing preclinical work and IND for SLE Well done @century_tx and @VersantVentures etc etc. Well done Dr. Greg Russotti ๐Ÿ‘"
X Link 2023-12-10T20:55Z [----] followers, [----] engagements

"BREAKING news biotwit it appears @yaireinhorn is back and not only will we get excellent content from him but also a chance to interact w great guy $XBI $ARKG #Genomics #crispr"
X Link 2024-01-06T20:27Z [----] followers, [----] engagements

"$CRBU [----] looking like it could be an inflection year. High expectations personally due to proven leadership and execution. * bias as have. large position here and not advice. https://investor.cariboubio.com/node/8326/pdf https://investor.cariboubio.com/node/8326/pdf"
X Link 2024-01-07T16:58Z [----] followers, [----] engagements

"If you follow me what I post on is my speculative biotech positions 98% of the time. For fun if I consider if I had to hold one or two indefinitely the list would be very short. Likely for me $CRBU makes the list with considerations of many variables. Starts w leadership"
X Link 2024-01-07T19:15Z [----] followers, [----] engagements

"$SANA ๐Ÿ”ฅ delayed reaction to yesterdays presentation"
X Link 2024-01-10T14:40Z [----] followers, [----] engagements

"$SANA $CRBU $FATE $IPSC cell therapy is back"
X Link 2024-01-10T15:22Z [----] followers, [----] engagements

"Remember things can change quickly in biotech land. Why personal DD and conviction is required. $IPSC * the bio shit company nobody wanted in 1.30s is now popular in 4s. Human emotion is very interesting and noise needs to at times be blocked. Hold the F line $IPSC https://t.co/dKE7qDAA2G Hold the F line $IPSC https://t.co/dKE7qDAA2G"
X Link 2024-01-23T02:52Z [----] followers, [----] engagements

"$IPSC $SANA Nice review of innate and adaptive immunity - $SANA and $IPSC - hypoimmune and Allo Evasion respectively try to block payload from immune detection. Have different methodology. Early data looks like both approaches may be effective. https://www.ncbi.nlm.nih.gov/books/NBK279396/ https://www.ncbi.nlm.nih.gov/books/NBK279396/"
X Link 2024-02-18T18:39Z [----] followers, [----] engagements

"$BEAM ๐Ÿ‘ I know one friend in here having a GREAT day today ๐Ÿ˜‰. ๐Ÿ”ฅ"
X Link 2024-02-27T15:34Z [----] followers, [----] engagements

"$SANA and $IPSC [--] excellent examples of why DD and conviction is important. Or perhaps you end up selling near lows at [----] and [----] respectively. Congrats to those who held strong Biotech is not easy"
X Link 2024-03-01T15:18Z [----] followers, [----] engagements

"1). My notes from $CRBU CEO Dr. Rachel Haurwitz discussion at Leerink * my interpretations not advice and may contain errors"
X Link 2024-03-13T06:00Z [----] followers, 17K engagements

"Favorite biotech themes and companies: Engineered cell therapy (allogeneic) - $IPSC $SANA $CRBU $LVTX CRISPR - $CRSP $NTLA Base editing - $BEAM PRIME editing - $PRME RNAi - $ARWR TechBio - $RXRX Biopharma - $XERS *not advice and do own DD **buy/sell often around core"
X Link 2024-04-24T03:17Z [----] followers, 11.4K engagements

"$CRBU Missed this presentation that was on 4/20/24. Safety is not even comparable and looking at subgroup efficacy should make patients AND investors excited. Huge and comical the current cash on hand to MC ratio. More buying tomorrow. $XBI https://investor.cariboubio.com/static-files/7b62813f-89af-48ae-97bb-4d16a9a82b4f https://investor.cariboubio.com/static-files/7b62813f-89af-48ae-97bb-4d16a9a82b4f"
X Link 2024-04-25T01:28Z [----] followers, 15K engagements

"Who else is excited and looking forward to @mellowrk_lion s return (hopeful return) Continued prayers to you and your family during this difficult time"
X Link 2024-05-04T21:37Z [----] followers, [----] engagements

"$CRSP doubled position"
X Link 2024-05-09T14:59Z [----] followers, [----] engagements

"Wishing $DNA shareholders the best of luck for a nice recovery. I sold most today as need to practice what I like to preach why keep $ invested in a company/leadership I no longer believe in. I still have a tiny position that Ill check in about [--] years. 1/2"
X Link 2024-05-11T06:34Z [----] followers, [----] engagements

"$CRBU some folks do understand that a PR can become CR. This data is still F***** impressive imo *biased as long many shares and still adding https://investor.cariboubio.com/static-files/3168b9f6-48dd-4e44-8103-df5ff9013b6b https://investor.cariboubio.com/static-files/3168b9f6-48dd-4e44-8103-df5ff9013b6b"
X Link 2024-05-17T22:05Z [----] followers, [----] engagements

"$CRBU the HLA (phenotype) data for CB-010 will be very interesting and could change the allogeneic cell therapy space imo. Hard to believe it wont be strong when Rachel seems to be very excited whenever she discussed it"
X Link 2024-05-28T03:28Z [----] followers, [----] engagements

"Extremely nice validation from one of the best in the business $ARWR Well done @ArrowheadPharma ๐Ÿ‘ From human genetics validation to a drug at Phase 2: it's a long road baby ANGPTL3: 14y APOC3: 16y Congrats to @ArrowheadPharma on the successful Ph2 results for siRNAs targeting ANGPTL3 and APOC3 https://t.co/7efOCu2l4V From human genetics validation to a drug at Phase 2: it's a long road baby ANGPTL3: 14y APOC3: 16y Congrats to @ArrowheadPharma on the successful Ph2 results for siRNAs targeting ANGPTL3 and APOC3 https://t.co/7efOCu2l4V"
X Link 2024-05-30T01:04Z [----] followers, [----] engagements

"$NTLA STELLAR data here * Long Id imagine @GeneInvesting is thrilled with this update Thanks @yaireinhorn ๐Ÿ‘Š for sharing 1/@intelliatx announced long-term data from its Phase 1/2 study of $NTLA-2002. A Single dose of NTLA-2002 led to a 98% mean reduction in monthly HAE attack rate with an average follow-up of [--] months across all patients & 8/10 patients remain completely attack-free. $XBI https://t.co/tdvsPRIMzf 1/@intelliatx announced long-term data from its Phase 1/2 study of $NTLA-2002. A Single dose of NTLA-2002 led to a 98% mean reduction in monthly HAE attack rate with an average"
X Link 2024-06-02T13:35Z [----] followers, [----] engagements

"Conviction plays for rest of year - not advice and due to MY DD and risk tolerance Id sell some or all if valuation pops for any could be a down year as crushed last year Down around 10% YTD (biotech only) [--]. $ARWR [--]. $XERS [--]. $IPSC (value / potential) 1/2"
X Link 2024-06-08T19:31Z [----] followers, [----] engagements

"๐Ÿ˜… I hope these are the last shares of $CRBU I had the opportunity to buy at these low price levels. Officially overweight"
X Link 2024-07-05T14:24Z [----] followers, [----] engagements

"Gotta love biotech $XBI after [--] months of losing and dropping to - 21% last week YTD back to green after this week ๐Ÿ˜‚. Have a great weekend folks and cheers ๐Ÿป * next week will be telling if this run has legs or was a bounce off severe oversold ** biotech investing is hard"
X Link 2024-07-12T20:08Z [----] followers, [----] engagements

"$ARWR exceptional data and the market HAS to start noticing. Will be adding more on any signs of weakness this week And to shut up all the analysts suggesting $ARWR's superior results were driven by inclusion of MCS (multifactorial FCS).no real difference there. $ARWR just doubled the market opportunity for their ApoCIII drug. sHTG (in development) will 100x it. $IONS https://t.co/VnZjKdk5Kf And to shut up all the analysts suggesting $ARWR's superior results were driven by inclusion of MCS (multifactorial FCS).no real difference there. $ARWR just doubled the market opportunity for their"
X Link 2024-09-02T17:51Z [----] followers, [----] engagements

"$ARWR borderlines comical stock price reaction. The market really does not like @ArrowheadPharma As long as they keep executing and demonstrating data like this Im happy to be long"
X Link 2024-09-03T19:15Z [----] followers, [----] engagements

"$CRBU I expect to eat very well 1H [----]. Personal price expectations 5-8. 9/24 - https://investor.cariboubio.com/static-files/f0890076-5d11-4e2b-8b1c-dfd5ad18c1e0 https://investor.cariboubio.com/static-files/f0890076-5d11-4e2b-8b1c-dfd5ad18c1e0"
X Link 2024-09-26T00:26Z [----] followers, [----] engagements

"$ARWR $CRBU $CRSP $IPSC Large positions that pass my litmus test when holding a bag. Would I buy and how much at current prices if had no position. It would honestly be like Christmas biotech can be very trying yet in my experience the rotation / pivot can be very quick"
X Link 2024-10-13T02:14Z [----] followers, [----] engagements

"Updated biotech holdings *excluding small positions $ARWR $ARCT $CRSP $PRME $BEAM $MGX $IPSC $CRBU $XERS $VKTX $KYTX Most positions include core shares and swing shares * biotech positions = 13% of stock portfolio"
X Link 2024-11-15T23:31Z [----] followers, [----] engagements

"$ARWR $CRBU $FATE $IPSC $PSTX Arrowhead massive partnership news (cash infusion /equity) and substantial premium for cell therapy player Poseida therapeutics Note- IPSC trades about [---] M below cash position ๐Ÿ˜‚"
X Link 2024-11-26T13:54Z [----] followers, [----] engagements

"Updated biotech holdings (Jan 2025) *excluding small positions $ARWR $ARCT $CRSP $PRME $BEAM $NTLA $BBIO $HUMA $IPSC $CRBU $XERS $KYTX $FATE Most positions include core shares and swing shares and not ordered by size * biotech positions = 12% of stock port"
X Link 2025-01-04T20:29Z [----] followers, 13.4K engagements

"Admittedly starting to think @GeneInvesting is CORRECT regarding $NTLA. I have small position here that will be increased next week pending no material news / events. Upside downside risk and healthy risk / reward imho. Not advice Damn say what you will about the stock price but the CEO went for blood here. Some of the best soundbites from JPM $NTLA If he buys stock this will exponentially sound 10x better. Some very interesting comments Surprised by his 1/5 and 90% comments for different reasons. https://t.co/pYosfITJcC Damn say what you will about the stock price but the CEO went for blood"
X Link 2025-01-19T01:05Z [----] followers, [----] engagements

"A total of [--] phase I / II / III assets in the clinic for @ArrowheadPharma This is impressive and many ambitious / lucrative targets $ARWR 1/3 https://arrowheadpharma.com/pipeline/ https://arrowheadpharma.com/pipeline/"
X Link 2025-01-20T02:34Z [----] followers, [----] engagements

"Loaded $ARWR at [-----] - minimum will hold these till the tap fills. My largest and most convicted biotech investment"
X Link 2025-02-11T19:04Z [----] followers, [----] engagements

"Updated biotech holdings (April 2025) Active last few weeks $XERS - entire position was sold 5.5-5.9 recently and am slowly buying back in $ARWR - added $CRSP - added $BBIO - sold around [--] and will be buying back Monday $IPSC - very red but holding on adding and may not even at these prices $FATE - most concentrated position and very bullish here. Position tripled over last [--] weeks. $NTLA - too cheap. $HUMA - exited at [--] over 50% loss $CRBU - really like the CEO yet sold position this week (funds moved all to FATE). For tax reasons and more confidence in other cell therapy plays. Likely"
X Link 2025-04-11T21:51Z [----] followers, 15.4K engagements

"@BillAckman Whats your point here Bill Do you want us to be amazed some can afford this Extremely out of touch tweet ๐Ÿ˜‚"
X Link 2025-04-25T04:21Z [----] followers, [----] engagements

"Finally finally finally this message (which is true) is gaining traction. $CRSP $PRME $BEAM $XBI $ARKG Sunnier pastures elsewhere shorts. Also never wise to short medicine / therapies that can influence modify and IMPROVE quality of life for many folks .@SecKennedy said yesterday at the FDA: "CRISPR gives the gift of life." He is 100% correct. I appreciate HHS FDA CMS NIH and CBER leadership devoting their morning to communicate their clear support for CRISPR giving such a gift to all of our nation's children who need it. .@SecKennedy said yesterday at the FDA: "CRISPR gives the gift of"
X Link 2025-06-07T04:15Z [----] followers, [----] engagements

"$MSOS @JDVance @elonmusk @VivekGRamaswamy @realDonaldTrump fair question How is cannabis a schedule I but fentanyl that kills millions is schedule ll Something is broken and needs fixing How is cannabis a schedule I but fentanyl that kills millions is schedule ll Something is broken and needs fixing"
X Link 2025-06-10T20:24Z [----] followers, [----] engagements

"Spectacular data $NTLA ๐Ÿ‘ Market cant really dispute this data. ๐Ÿ’ช Thanks @yaireinhorn for sharing Nice to see good news to contrast the nice 1am PR by $SRPT ๐Ÿคฎ 1/๐ŸšจWOW @intelliatx presented new data from a 3-year follow-up which showed that a single dose of lonvo-z - $NTLA-2002 led to a 98% () reduction in monthly HAE attack rate & all [--] patients were attack-free for a median of [--] months through the latest follow-up. #EHA2025 $XBI https://t.co/hi73VKtJuZ 1/๐ŸšจWOW @intelliatx presented new data from a 3-year follow-up which showed that a single dose of lonvo-z - $NTLA-2002 led to a 98% ()"
X Link 2025-06-15T18:15Z [----] followers, [----] engagements

"Congrats (kind of) $VERV shareholders So needed for the sector ๐Ÿ‘ Cheap for Eli Lilly"
X Link 2025-06-17T01:41Z [----] followers, [----] engagements

"As someone who has been monitoring and critical of the financial status of $PRME I think its a little overdone. They will eventually raise no doubt but they have some heavy hitters including Alphabet (15m shares) BMY (11m shares) and Arch (15m shares) and do not think finding more backers will be challenging. ๐Ÿ‘€ with $GOOG having a strong position. Partnerships / licensing deals also can bring in fresh capital. (L)"
X Link 2025-06-21T22:33Z [----] followers, [----] engagements

"Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most recent inside buying is from arguably one of the greatest scientist ever. Not advice. As someone who has been monitoring and critical of the financial status of $PRME I think its a little overdone. They will eventually raise no doubt but they have some heavy hitters including Alphabet (15m shares) BMY (11m shares) and Arch (15m shares) and do not think https://t.co/qm9xeYPNfh As someone who has been"
X Link 2025-06-22T18:48Z [----] followers, 16.3K engagements

"David ADDED again $PRME Not trying to be redundant but this is very bullish in my opinion #blackjack Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most recent inside buying is from arguably one of the greatest scientist ever. Not https://t.co/TH9e3cj5i3 Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down [--] to 90% in this sector yet insiders have been quiet WEAKNESS Not the case here. Oh yeah the most"
X Link 2025-06-24T00:47Z [----] followers, [----] engagements

"$ARWR starting to think a BO would not be in the long term best interests of shareholders. @ArrowheadPharma s valuation wont be able to be held down much longer with their late stage assets and strong early programs. I plan to enjoy the ride"
X Link 2025-08-08T15:11Z [----] followers, [----] engagements

"Incredibly illogical and stupid that marijuana is classified the same as drugs such as heroin $MSOS Will be so ironical if conservatives make this change after years and years of promises from democrats"
X Link 2025-08-10T17:45Z [----] followers, [----] engagements

"Back in $PRME I say this often but plan to just let these sit for the coming years. Worth the risk imo"
X Link 2025-08-12T15:34Z [----] followers, [----] engagements

"$SRPT position now full. Plan / hope is to hold till [--] ish. Always subject to change"
X Link 2025-08-26T21:47Z [----] followers, [----] engagements

"Biotech $XBI โžก big tech $QQQ #2026 $SPY $ARKG $ARKK"
X Link 2025-12-12T15:28Z [----] followers, [---] engagements

"@JessieChimni You nailed your timing on reentering this one ๐Ÿ”ฅ The reverse split no longer appear appears a foregone conclusion. I would guess your speculation that this move is tied to [---] is likely correct . Or it could be another fund loading loke point72"
X Link 2026-01-08T03:34Z [----] followers, [---] engagements

"@HeidingOut @steve2bacon lol just messaged Steve that the next play I need to do a better job getting in closer to the bottom. Definitely on the look out another similar opportunity ๐Ÿ”ฅ"
X Link 2026-01-16T03:29Z [----] followers, [--] engagements

"Yes $FATE is a very legit recommendation. Now $FATE is valued way too low relative to its peers. Its been a good trade from 1-1.60 yet from an investing standpoint it has a very high ceiling. @JessieChimni has done great analysis on it; science and finance. Great follow by the way. https://twitter.com/i/web/status/2012005723920875994 https://twitter.com/i/web/status/2012005723920875994"
X Link 2026-01-16T03:35Z [----] followers, [---] engagements

"@JessieChimni Nice volume for $FATE today ๐Ÿ‘Š"
X Link 2026-01-16T18:45Z [----] followers, [---] engagements

"$FATE around [---] continues to be a stellar trade ๐Ÿ”ฅ"
X Link 2026-01-22T16:43Z [----] followers, [---] engagements

"$IPSC really doesnt make sense me how much institutional buying has taken place the last few months yet price has been crushed. Besides Avidity selling I see nothing but massive adds. Some big adds also by Venrock and Boxer. Wildcard would be Versant with no filings Q1"
X Link 2024-09-14T23:41Z [----] followers, [----] engagements

"@RazorSharpDNA Happens man. Thats what I did with CRBU last year around .8 ๐Ÿคฃ"
X Link 2026-01-16T22:40Z [----] followers, [---] engagements

"@RazorSharpDNA I am still keeping an eye on CRBU and always have liked Rachel. Routing for them but also maybe would jump in if it gets too low"
X Link 2026-01-16T23:13Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing